Familial hypertrophic cardiomyopathy

Familial hypertrophic cardiomyopathy: A genetic disorder of the heart characterized by increased growth (hypertrophy) in thickness of the wall of the left ventricle, the largest of the four chambers of the heart.

Familial hypertrophic cardiomyopathy (FHCM) can surface any time in life. It may, in a worst-case scenario, lead to death. One in about 500 people have FHCM. Five to 10%of people with FHCM suffer fatal cardiac arrest. It is the leading cause of sudden death in athletes and young people.

Former US Defense Secretary Les Aspin died in 1995 at 56 from a stroke linked to the disorder. John Stewart, a 7-foot University of Kentucky basketball recruit, collapsed and died of the disease during a high school tournament game in 1999.

A measurement of the thickness of the left ventricle wall can predict who is most at risk for FHMC. The test is done by echocardiography, a routine ultrasound test of the heart. Persons with a maximum wall thickness less than three-quarters of an inch (19 mm) are virtually free of risk for fatal cardiac arrest over 20 years whereas those with a wall thickness more than 1.2 inches (30 mm) have a 40% chance of fatal cardiac arrest during that time period. Patients in danger can be fitted with implantable defibrillators, which can shock a spasmodic heart back to life.

The disease exhibits an autosomal dominant pattern of inheritance. Men and women with FHCM stand a 50-50 chance of transmitting the FHCM gene to each of their children. There are various kinds of FHCM (symmetrical, asymmetrical forms, etc.). Genes for the disorder have been mapped to chromosomes 14q12 and 15q14.

FHCM is also known by other names including hypertrophic cardiomyopathy (HCM), hereditary ventricular hypertrophy, asymmetrical septal hypertrophy (ASH), and hypertrophic subaortic stenosis.

Read Also:

  • Familial juvenile nephronophthisis (FJN)

    Familial juvenile nephronophthisis (FJN): A childhood genetic kidney disease in which there is progressive symmetrical destruction of the kidneys involving both the tubules and glomeruli, characteristically resulting in anemia, polyuria, polydipsia, isosthenuria (decreased ability to concentrate the urine), progressive renal failure and death in uremia. Hypertension and proteinuria are conspicuous by their absence. The chronic […]

  • Familial lung cancer

    Familial lung cancer: Lung cancer that recurs in families. Lung cancer can occur sporadically in people with no known family history of lung cancer or it can occur in two or more members of the same family and constitute familial lung cancer. A gene for familial lung cancer is on the long (q) arm of […]

  • Familial Mediterranean fever (FMF)

    Familial Mediterranean fever (FMF): An inherited disorder featuring short recurring crises of severe abdominal pain and bouts of fever. Other symptoms include arthritis, chest pain from inflammation of the lung cavity, and skin rashes. Between attacks, the patient seems healthy. Amyloidosis (the abnormal deposition of a particular protein, called amyloid, in various tissues of the […]

  • Familial Parkinson disease type 1

    Familial Parkinson disease type 1: A familial form of Parkinson disease inherited in an autosomal dominant manner due to mutation in the alpha-synuclein gene (SNCA) on chromosome 4q21. Also known as PARK1.

  • Familial Parkinson disease type 10

    Familial Parkinson disease type 10: A familial form of Parkinson disease inherited in an autosomal dominant manner due to a gene on chromosome 1p. Also known as PARK10.

Disclaimer: Familial hypertrophic cardiomyopathy definition / meaning should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional. All content on this website is for informational purposes only.